Stryker lowers 2026 guidance after slowdown in hip, knee procedures

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 30 Oct, 14:23 UTC

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also detailed the company’s decision to partner with CMR Surgical.

science

Sources

• T2Stryker lowers 2026 guidance after slowdown in hip, knee proceduresBioPharma Dive / Healthcare Dive / MedTech Dive30 Oct, 14:23